CONSTELLATION PHARMACEUTICALS INC

Profile

Company Names

CONSTELLATION PHARMACEUTICALS INC

Addresses

215 FIRST STREET, SUITE 200, CAMBRIDGE, MA 02142

148 SIDNEY STREET, CAMBRIDGE, MA 02139

Phone Numbers

617-714-0555
617-864-0676

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$286,372,402.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-10-01 
$64,999,985.00 
$64,999,985.00 
$0.00 
Equity 
6
2018-03-22 
$99,000,000.00 
$100,000,000.00 
$1,000,000.00 
Equity 
5
2016-09-13 
$24,298,209.00 
$24,298,209.00 
$0.00 
Equity 
4
2015-12-01 
$55,824,208.00 
$55,824,208.00 
$0.00 
Equity 
3
2014-08-05 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
2
2011-05-23 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
1
2010-05-24 
$22,250,000.00 
$22,250,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
E. 
AUDIA 
EXECUTIVE OFFICER, DIRECTOR
CONSTELLATION PHARMACEUTICALS INC
GAREN 
 
BOHLIN 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC   |  ACUSPHERE INC   |  SPRINGLEAF THERAPEUTICS, INC.   |  COLLEGIUM PHARMACEUTICAL, INC   |  PROTEON THERAPEUTICS INC   |  TETRAPHASE PHARMACEUTICALS INC   |  CURADEL SURGICAL INNOVATIONS, INC.
SCOTT 
 
BRAUNSTEIN 
DIRECTOR
ZIOPHARM ONCOLOGY INC   |  BWBC I LLC   |  CONSTELLATION PHARMACEUTICALS INC   |  AEGLE THERAPEUTICS CORP
MICHAEL 
R. 
COOPER 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC
KEITH 
 
DIONNE 
EXECUTIVE OFFICER, DIRECTOR
SURFACE LOGIX INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PIQUE THERAPEUTICS, INC.
ANTHONY 
 
EVNIN 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  METABOLEX, INC.   |  ACCELERON PHARMA INC   |  BOSTON POWER INC   |  CONSTELLATION PHARMACEUTICALS INC   |  ALTEA THERAPEUTICS CORP   |  JUNO THERAPEUTICS, INC.
DAVID 
 
GOEDDEL 
DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
MARK 
A. 
GOLDSMITH 
EXECUTIVE OFFICER, DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  IGENICA INC   |  REVOLUTION MEDICINES, INC.
EDWARD 
E. 
HARLOW, JR. 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC
STEVEN 
 
HOERTER 
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC
MATTHIAS 
 
JAFFE 
EXECUTIVE OFFICER
ZAFGEN, INC.   |  CONSTELLATION PHARMACEUTICALS INC
MARK 
 
LEVIN 
DIRECTOR
NINEPOINT MEDICAL, INC.   |  ELEVEN BIOTHERAPEUTICS, INC.   |  CONSTELLATION PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  KARSAMERICA FINANCE LLC   |  DC DEVICES, INC.   |  THIRD ROCK VENTURES III, L.P.   |  ALLSTAR DEALS, INC.   |  MAKI SHOP STORE 1 LLC   |  ROLL-D HOLDINGS, LLC   |  VOYAGER THERAPEUTICS, INC.   |  CORVIA MEDICAL, INC.   |  FULCRUM THERAPEUTICS, INC.   |  MAKI SHOP STORE 3 LLC   |  HIRSHMARK CAPITAL REIT LLC
TOM 
 
MANIATIS 
DIRECTOR
ACCELERON PHARMA INC   |  CONSTELLATION PHARMACEUTICALS INC   |  KALLYOPE, INC.
STEVEN 
 
PAUL 
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  SAGE THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  SEAPORT THERAPEUTICS, INC.
JIGAR 
 
RAYTHATHA 
EXECUTIVE OFFICER, DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  TRIANA BIOMEDICINES, INC.
EMMA 
 
REEVE 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  AADI BIOSCIENCE, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  REALTA LIFE SCIENCES, INC.
KERRY 
K. 
REINERTSEN 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC
ADRIAN 
 
SENDEROWICZ 
EXECUTIVE OFFICER
CERULEAN PHARMA INC.   |  CONSTELLATION PHARMACEUTICALS INC
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
ROBERT 
 
TEPPER 
DIRECTOR
CERULEAN PHARMA INC.   |  ALNARA PHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  KALA PHARMACEUTICALS, INC.   |  BLUEBIRD BIO, INC.   |  THIRD ROCK VENTURES III, L.P.   |  ALLENA PHARMACEUTICALS, INC.   |  JOUNCE THERAPEUTICS, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  NEON THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  FAZE MEDICINES, INC.   |  THIRD ROCK VENTURES VI, L.P.
ELIZABETH 
G. 
TREHU 
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  JOUNCE THERAPEUTICS, INC.
PATRICK 
 
TROJER 
EXECUTIVE OFFICER
CONSTELLATION PHARMACEUTICALS INC   |  TRIANA BIOMEDICINES, INC.
KAREN 
 
VALENTINE 
EXECUTIVE OFFICER
ANTIGENICS INC /DE/   |  AGENUS INC   |  CONSTELLATION PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-10-01 
2018-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-22 
2016-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-13 
2015-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-01 
2014-08-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-05 
2011-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-23 
2010-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#